NeuroTechX Services (@ntxservices) 's Twitter Profile
NeuroTechX Services

@ntxservices

The ultimate NeuroTechnology solution for your Consulting and Recruiting needs!

ID: 1381991965160521729

linkhttps://neurotechx-services.com/ calendar_today13-04-2021 15:25:58

215 Tweet

151 Followers

32 Following

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Interested in investing in #neuroscience? This article provides a thorough explanation as to why that may be a good idea. Give it a read to learn more about the #financial aspect of the #neurotech industry: ow.ly/AoLG50Kz2MR

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

This #accessible and in-depth video from Al Jazeera English (Al Jazeera English) is a great watch for anyone curious about the future of #mentalhealth care, and how it may be affected by increasing digitalization: ow.ly/tBI350Kz34w #DTx #neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

A Danish consumer #neuroscience company, Neurons, has raised over 6 million Euros, “one of the largest global seed rounds ever” in Denmark. The company will be using these funds to “attract new talent”, and “scale [their] predictive tools” ow.ly/XpIZ50Kz3E0 #neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

The WVU Rockefeller Neuroscience Institute has launched a "#clinical trial pairing focused ultrasound treatment with Alzheimer’s antibody drug therapy to a targeted" #brain area, potentially opening a new treatment option for #Alzheimers: ow.ly/8RnP50Kz3V2 #neuroscience

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Meta has acquired #Berlin based startup Lofelt “for better #VR and #AR haptics.” A key building block of an immersive #metaverse, Lofelt’s #haptic technology will help Meta “[map] the illusion of touch in virtual reality.” ow.ly/uJj650KH7hl #neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

This commentary in FORTUNE is a considered critique of the way #DTx start-ups often engage with the traditional #MentalHealth industry & provides some solutions and ideas for ways both can work together to improve patient outcomes: ow.ly/ekH050KIIE4 #neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Public #healthcare clusters in Singapore are testing new healthcare technologies “for potential future adoption and large-scale implementation.” Six near-market-ready solutions were awarded a total of $1.7 million in funding: ow.ly/bcTk50KMjm7 #DTx #startups #neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

This video from HIMSS 2022 Europe explores why & how #AI is “expected to be [the] most disruptive tool in digital health.” This global #health conference explores & interrogates cutting-edge health IT solutions: ow.ly/1Zva50KN3C5 #DTx #neurotech #FutureofHealthcare

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

This op-ed in Medical Tech Outlook explores the importance of building positive patient rapport & how that enhances the “patient experience in telehealth.” #Rapport can be underestimated by #DTx developers & providers: ow.ly/R2Ni50KN4gZ #telehealth #neurotech

NeuroTechX (@neurotechx) 's Twitter Profile Photo

#ICYMI - The September issue of the NeuroTechX #newsletter gives you direct access to the latest on #neurotech news, #jobs, and events. Read and sign up here: ow.ly/EJwQ50KTOw0

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Pain is a highly personal experience. The #FDA approved @Nevro_HFX's Senza HFX iQ spinal cord stimulation which uses #AI to assess a patient's responses to automatically recommend adjustments to optimize efficacy of the #neurostimulation treatment. ow.ly/Gi9E50LalvQ

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Neurotech companies are making their way through the #FDA process. Axoft novel technology builds on Dr. Liu’s work developing materials and designs of ultra-flexible nanoelectronics to mimic the mechanical and structural properties of the brain. ow.ly/wzmG50LePJY

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Notes from AdvaMed's MedTech Conference in Boston today highlight the changing regulatory landscape for Medical Devices: ow.ly/6P4g50LkEb3 Insights include issues around transparency in #AI, patient-centric views & int'l harmonization for #DTx players #Reg

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Synchron continues to make strides in #neurotech by beginning patient enrollment in its COMMAND trial to explore efficacy measures of its Sentrode device in patients with severe paralysis to enable patients to control digital devices, hands free. ow.ly/KzpW50LnrEJ

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Innovation in #Epilepsy continues with collaborations between established #pharmas and #neurotech, as this commercialization agreement between Neuraxpharm Spain & mjn-neuro highlights finance.yahoo.com/news/neuraxpha… #Partnerships #Neurotech #Europe

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Although its not #neuro, this pilot program run by New Orleans based Ochsner Health highlights how access to #DTx with remote patient management can improve outcomes from #Medicaid patients with #chronic diseases. ow.ly/S5l850LkJW1

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

📣 New Fund Alert 📣 Time BioVentures, an LA-based early-stage life sciences venture firm, closed its first fund with $100M in AUMs. ow.ly/6XU550Lnscg

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Close to 6,500 #MedTech companies in the US, dedicated to transforming healthcare were found to drive a 60% decrease in patient days spent in hospital over the course of two decades, according to this source: ow.ly/eekU50LkLEj #Healthcare #PatientOutcomes #Neurotech

NeuroTechX Services (@ntxservices) 's Twitter Profile Photo

Fresh off the press! Synchron raises $75M from ARCH Venture Partners, Gates Frontier, Bezos Expeditions, Reliance Digital Health, Greenoaks, Alumni Health Ventures, Moore Strategic Ventures, and Project X with follow ons from current investors ow.ly/AeON50M4FTJ